1. Home
  2. GMRE vs AXGN Comparison

GMRE vs AXGN Comparison

Compare GMRE & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GMRE
  • AXGN
  • Stock Information
  • Founded
  • GMRE 2011
  • AXGN N/A
  • Country
  • GMRE United States
  • AXGN United States
  • Employees
  • GMRE N/A
  • AXGN N/A
  • Industry
  • GMRE Real Estate Investment Trusts
  • AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • GMRE Real Estate
  • AXGN Health Care
  • Exchange
  • GMRE Nasdaq
  • AXGN Nasdaq
  • Market Cap
  • GMRE 485.5M
  • AXGN 538.3M
  • IPO Year
  • GMRE N/A
  • AXGN N/A
  • Fundamental
  • Price
  • GMRE $6.19
  • AXGN $9.73
  • Analyst Decision
  • GMRE Buy
  • AXGN Strong Buy
  • Analyst Count
  • GMRE 3
  • AXGN 6
  • Target Price
  • GMRE $10.38
  • AXGN $23.83
  • AVG Volume (30 Days)
  • GMRE 699.2K
  • AXGN 595.0K
  • Earning Date
  • GMRE 08-05-2025
  • AXGN 08-07-2025
  • Dividend Yield
  • GMRE 12.60%
  • AXGN N/A
  • EPS Growth
  • GMRE N/A
  • AXGN N/A
  • EPS
  • GMRE 0.03
  • AXGN N/A
  • Revenue
  • GMRE $138,220,000.00
  • AXGN $194,520,000.00
  • Revenue This Year
  • GMRE $4.64
  • AXGN $18.08
  • Revenue Next Year
  • GMRE $3.78
  • AXGN $16.15
  • P/E Ratio
  • GMRE $193.38
  • AXGN N/A
  • Revenue Growth
  • GMRE N/A
  • AXGN 18.81
  • 52 Week Low
  • GMRE $6.06
  • AXGN $6.59
  • 52 Week High
  • GMRE $10.46
  • AXGN $21.00
  • Technical
  • Relative Strength Index (RSI)
  • GMRE 35.73
  • AXGN 32.26
  • Support Level
  • GMRE $6.17
  • AXGN $9.22
  • Resistance Level
  • GMRE $6.38
  • AXGN $11.24
  • Average True Range (ATR)
  • GMRE 0.14
  • AXGN 0.49
  • MACD
  • GMRE 0.04
  • AXGN 0.05
  • Stochastic Oscillator
  • GMRE 9.86
  • AXGN 22.67

About GMRE Global Medical REIT Inc.

Global Medical REIT Inc is engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Share on Social Networks: